Huntsman Carole's Form 4 filing
Madrigal Pharmaceuticals, Inc. (MDGL) · filed Jan 26, 2026
- Accession no.
- 0001628280-26-003482
- Filed
- Jan 26, 2026
- Trade date
- Jan 26, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $449.3K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Huntsman CaroleCIK 0002001571 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 26, 2026 | Common Stock | SSaleDisposed | −340 | $492.42 | −$167,422.8 | 9,692 | Direct | |
| Jan 26, 2026 | Common Stock | SSaleDisposed | −570 | $494.59 | −$281,916.3 | 9,122 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.